Form 8-K - Current report:
SEC Accession No. 0001601485-26-000041
Filing Date
2026-05-11
Accepted
2026-05-11 16:09:10
Documents
19
Period of Report
2026-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eltx-20260511.htm   iXBRL 8-K 24623
2 EX-99.1 eltx1q26pr.htm EX-99.1 18088
6 GRAPHIC eltx1q26pr001.jpg GRAPHIC 210285
7 GRAPHIC eltx1q26pr002.jpg GRAPHIC 167331
8 GRAPHIC eltx1q26pr003.jpg GRAPHIC 98857
9 GRAPHIC eltx1q26pr004.jpg GRAPHIC 177446
10 GRAPHIC eltx1q26pr005.jpg GRAPHIC 243323
11 GRAPHIC eltx1q26pr006.jpg GRAPHIC 266388
12 GRAPHIC eltx1q26pr007.jpg GRAPHIC 171859
  Complete submission text file 0001601485-26-000041.txt   2009264

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eltx-20260511.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eltx-20260511_lab.xml EX-101.LAB 22516
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eltx-20260511_pre.xml EX-101.PRE 13037
23 EXTRACTED XBRL INSTANCE DOCUMENT eltx-20260511_htm.xml XML 3107
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 26963248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)